Literature DB >> 24931295

Evaluation of Florida physicians' knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool.

Jennifer A Gershman1, Jason A Gershman, Andrea D Fass, Ioana Popovici.   

Abstract

OBJECTIVE: The purpose of this study is to assess Florida physicians' attitudes and knowledge toward accessing the state's prescription drug monitoring program (PDMP).
DESIGN: Five thousand medical doctors and osteopathic physicians licensed in Florida were randomly selected for a voluntary and anonymous 15-question self-administered survey approved by the Institutional Review Board. Surveys were distributed through U.S. postal service mail. Likert-scale questions were used to assess prior knowledge (1 = none to 5 = excellent) and attitudes toward accessing the PDMP (1 = strongly disagree to 5 = strongly agree).
RESULTS: The study yielded a response rate of 7.8%, 71.5% of whom agreed or strongly agreed that the PDMP is a useful tool. Among participants that have access and answered the PDMP usefulness question, 94.8% agree or strongly agree that it is a useful tool. There were 63 out of 64 physicians (98.4%) who conducted 25 or more searches who agreed or strongly agreed that the PDMP is a useful tool for monitoring patients' controlled substance histories. There were 72.5% of participants with access that answered the "doctor shopping" question who agreed that "doctor shopping" will decrease. Among the 64 most frequent PDMP users, 69.4% agreed or strongly agreed that they have prescribed fewer controlled substances after accessing the PDMP.
CONCLUSIONS: The study revealed that a majority of participants believe that the PDMP is a useful tool for monitoring patients' controlled substance histories. More continuing education programs should be provided to Florida physicians to enhance their knowledge regarding PDMPs. Wiley Periodicals, Inc.

Entities:  

Keywords:  Controlled Substances; Electronic-Florida Online Reporting Controlled Substance Evaluation; Physicians; Prescription Drug Monitoring Programs

Mesh:

Substances:

Year:  2014        PMID: 24931295     DOI: 10.1111/pme.12476

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  5 in total

1.  Perception of prescription drug monitoring programs as a prevention tool in primary medical care.

Authors:  Amie J Goodin; Joshua D Brown; Chris Delcher; Patricia R Freeman; Jeffery Talbert; Stephen G Henry; Dikea Roussos-Ross
Journal:  Res Social Adm Pharm       Date:  2019-03-26

Review 2.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

3.  Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.

Authors:  Patricia R Freeman; Geoffrey M Curran; Karen L Drummond; Bradley C Martin; Benjamin S Teeter; Katharine Bradley; Nancy Schoenberg; Mark J Edlund
Journal:  Res Social Adm Pharm       Date:  2018-09-14

4.  Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.

Authors:  Alysia Robinson; Maria N Wilson; Jill A Hayden; Emily Rhodes; Samuel Campbell; Peter MacDougall; Mark Asbridge
Journal:  Pain Med       Date:  2021-07-25       Impact factor: 3.750

5.  Impact evaluation of a brief online training module on physician use of the Maryland, USA, Prescription Drug Monitoring Program.

Authors:  Oluwasanmi O Adenaiye; Julia B Zirpoli; Marissa Tan; Brendan F Day; Olayiwola Bolaji; Clifford S Mitchell; Marianne Cloeren
Journal:  PLoS One       Date:  2022-08-09       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.